Humanigen and Lonza Announce Collaboration to Expand Manufacturing of Humanigen’s COVID-19 Therapeutic Candidate Lenzilumab
Collaboration to expand lenzilumab manufacturing capacity in advance of potential Emergency Use Authorization in 2020 Commercial manufacturing to begin in...